Neutral
Regentis Biomaterials (NYSE: RGNT) seeks to sell 3.33M shares; $3.00 assumed
Regentis Biomaterials (NYSE: RGNT) has filed an F-1 registration statement to sell 3,333,334 Ordinary Shares at an assumed public offering price of $3...